Table III.
Factor | Number of patients | Median DOR (months) | P-value |
---|---|---|---|
Bortezomib | |||
Yes | 14 | 11 | 0.046 |
No | 12 | 4 | |
Auto-SCT | |||
Yes | 9 | 16 | 0.012 |
No | 17 | 4.5 | |
Abnormality by FISH | |||
Yes | 10 | 6 | 0.617 |
No | 16 | 9 | |
EMP | |||
Yes | 10 | 6.5 | 0.667 |
No | 16 | 9 |
DOR, duration of remission; auto-SCT, autologous stem cell transplantation; abnormality by FISH, one of t(4;14), t(14;16) or del17p abnormalities by FISH; FISH, fluorescence in situ hybridization; EMP, extramedullary plasmacytoma.